Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2731 AL 2745

Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease

Kellar D, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S.

J Prev Alzheimers Dis. 2021;8(3):240-248. doi: 10.14283/jpad.2021.14.

Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?

Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M.

Neurosci Lett. 2021 Aug 24;760:136044. doi: 10.1016/j.neulet.2021.136044. Epub 2021 Jun 10.

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Cruchaga C, Goate AA, Perrin RJ, Xiong C, Li Y, Morris JC, Snider BJ, Mummery C, Surti GM, Hannequin D, Wallon D, Berman SB, Lah JJ, Jimenez-Velazquez IZ, Roberson ED, van Dyck CH, Honig LS, Sánchez-Valle R, Brooks WS, Gauthier S, Galasko DR, Masters CL, Brosch JR, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Jack CR Jr, Koeppe R, Snyder PJ, Aisen PS, Thomas RG, Berry SM, Wendelberger BA, Andersen SW, Holdridge KC, Mintun MA, Yaari R, Sims JR, Baudler M, Delmar P, Doody RS, Fontoura P, Giacobino C, Kerchner GA, Bateman RJ; Dominantly Inherited Alzheimer Network–Trials Unit.

Nat Med. 2021 Jul;27(7):1187-1196. doi: 10.1038/s41591-021-01369-8. Epub 2021 Jun 21.

Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease

Athar T, Al Balushi K, Khan SA.

Mol Biol Rep. 2021 Jul;48(7):5629-5645. doi: 10.1007/s11033-021-06512-9. Epub 2021 Jun 28.

Cellular Senescence and ApoE4: Their Repercussions in Alzheimer's Disease

Tecalco-Cruz AC, Zepeda-Cervantes J, López-Canovas L, Ramírez-Jarquín JO, Pedraza-Chaverrí J, Briones-Herrera A.

CNS Neurol Disord Drug Targets. 2021;20(9):778-785. doi: 10.2174/1871527320666210628102721.

Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease

Balendra V, Singh SK.

Open Biol. 2021 Jun;11(6):210013. doi: 10.1098/rsob.210013. Epub 2021 Jun 30.

Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer's Disease

Castaneda A, Ferraz R, Vieira M, Cardoso I, Vasconcelos V, Martins R.

Mar Drugs. 2021 Jun 16;19(6):343. doi: 10.3390/md19060343.

The next step of neurogenesis in the context of Alzheimer's disease

Moradi HR, Hajali V, Khaksar Z, Vafaee F, Forouzanfar F, Negah SS.

Mol Biol Rep. 2021 Jul;48(7):5647-5660. doi: 10.1007/s11033-021-06520-9. Epub 2021 Jul 7.

Role of TREM2 in Alzheimer's Disease: A Long Road Ahead

Kulkarni B, Kumar D, Cruz-Martins N, Sellamuthu S.

Mol Neurobiol. 2021 Oct;58(10):5239-5252. doi: 10.1007/s12035-021-02477-9. Epub 2021 Jul 18.

Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials

Mortby ME, Adler L, Agüera-Ortiz L, Bateman DR, Brodaty H, Cantillon M, Geda YE, Ismail Z, Lanctôt KL, Marshall GA, Padala PR, Politis A, Rosenberg PB, Siarkos K, Sultzer DL, Theleritis C; ISTAART NPS PIA.

Am J Geriatr Psychiatry. 2022 Feb;30(2):119-147. doi: 10.1016/j.jagp.2021.06.016. Epub 2021 Jul 1.

High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics

Jin Y, Chifodya K, Han G, Jiang W, Chen Y, Shi Y, Xu Q, Xi Y, Wang J, Zhou J, Zhang H, Ding Y.

J Control Release. 2021 Oct 10;338:56-70. doi: 10.1016/j.jconrel.2021.08.018. Epub 2021 Aug 13.

Retinal Dysfunction in Alzheimer's Disease and Implications for Biomarkers

Liao C, Xu J, Chen Y, Ip NY.

Biomolecules. 2021 Aug 16;11(8):1215. doi: 10.3390/biom11081215.

The Amyloid-β Pathway in Alzheimer's Disease

Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A.

Mol Psychiatry. 2021 Oct;26(10):5481-5503. doi: 10.1038/s41380-021-01249-0. Epub 2021 Aug 30.

Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach

Sharma S, Behl T, Kumar A, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S.

Biomed Res Int. 2021 Sep 6;2021:7396580. doi: 10.1155/2021/7396580. eCollection 2021.

Current directions in tau research: Highlights from Tau 2020

Sexton C, Snyder H, Beher D, Boxer AL, Brannelly P, Brion JP, Buée L, Cacace AM, Chételat G, Citron M, DeVos SL, Diaz K, Feldman HH, Frost B, Goate AM, Gold M, Hyman B, Johnson K, Karch CM, Kerwin DR, Koroshetz WJ, Litvan I, Morris HR, Mummery CJ, Mutamba J, Patterson MC, Quiroz YT, Rabinovici GD, Rommel A, Shulman MB, Toledo-Sherman LM, Weninger S, Wildsmith KR, Worley SL, Carrillo MC.

Alzheimers Dement. 2022 May;18(5):988-1007. doi: 10.1002/alz.12452. Epub 2021 Sep 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias